Skip to main content

BIOLIFE SOLUTIONS INC

For the period ended Dec 31, 2024. Filed Mar 3, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 3, 2025

BLFS$38.61+3.5%Stored close · as of Oct 5, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows

Year Ended December 31,
(In thousands)202420232022
Cash flows from operating activities
Net loss$(20,184)$(68,002)$(139,805)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
Impairment of intangible assets—5,758110,364
Impairment of long-lived assets—9,727—
Gain on settlement of Global Cooling escrow—(5,115)—
Depreciation5,1607,1146,775
Amortization of intangible assets3,5015,1819,697
Amortization of loan costs—1318
Stock-based compensation30,92333,24525,334
Non-cash lease expense4244043,486
Deferred income tax benefit(64)(62)(5,238)
Change in fair value of contingent consideration—(2,193)(4,754)
Change in fair value of investments4,074—(697)
Accretion of investments(474)(1,262)(447)
Loss on disposal of assets held for rent, net567594773
Loss on disposal of property and equipment, net154633745
Net gain on disposal of subsidiaries(15,877)——
Other——166
Change in operating assets and liabilities
Accounts receivable, trade, net(2,899)15,351(10,753)
Inventories781(8,552)(6,559)
Prepaid expenses and other current assets(2,407)13726
Accounts payable26(8,425)414
Accrued expenses and other current liabilities6,4852,0021,787
Sales taxes payable(973)1,3111,526
Warranty liability(528)(454)(1,086)
Other(258)97(260)
Net cash provided by (used in) operating activities8,431(12,498)(8,488)
Cash flows from investing activities
Purchases of property and equipment(3,227)(6,381)(10,385)
Purchases of assets held for rent(2,068)(4,856)(3,536)
Proceeds from sale of available-for-sale securities3,5183,469420
Maturities of available-for-sale securities18,40052,7008,500
Investment in available-for-sale securities(18,415)(27,095)(53,116)
Purchases of intangible assets(300)——
Proceeds from sale of SciSafe and CBS73,431——
Payments on divestiture of Global Cooling(13,039)——
Net cash provided by (used in) investing activities58,30017,837(58,117)
Cash flows from financing activities
Proceeds from term loan——20,000
Payments on term loan(5,000)(300)(1,666)
Payments on equipment loans(1,608)(198)(498)
Issuance of common stock—10,244—
Fees paid related to issuance of common stock——(131)
Proceeds from exercise of common stock options202507323
Proceeds from financed insurance premium2,0942,639—
Payments on financed insurance premium(2,397)(2,365)(1,375)
Other(74)64(337)
Net cash (used in) provided by financing activities(6,783)10,59116,316
Net increase in cash and cash equivalents59,94815,930(50,289)
Cash and cash equivalents – beginning of period35,43819,47369,870
Effects of currency translation on cash and cash equivalents—35(108)
Cash and cash equivalents – end of period$95,386$35,438$19,473
Non-cash investing and financing activities
Assets acquired under operating leases$5,833$880$243
Assets acquired under finance leases$—$1,682$—
Purchase of property and equipment not yet paid$107$359$478
Unrealized (gain) loss on available-for-sale securities$(18)$(56)$50
Unrealized gain on currency translation$—$(12)$—
Cashless issuance of SciSafe earnout shares$—$2,263$817
Returned shares from settlement of Global Cooling escrow$—$(5,115)$—
Cash interest paid$1,608$1,927$586
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.